Mayo Pujols

Mayo Pujols

Chief Technical Officer, Executive Vice PresidentatRocket Pharmaceuticals· In proxies 2022–2023

Pay in FY2023+39% from the year before · Rocket Pharmaceuticals stock +53.1% the same year

Mayo Pujols was paid $4.4M in FY2023 (Dec), up 39%. Rocket Pharmaceuticals stock rose 53.1% that year.

Pay$100 in the stock at the end of FY21 → $137
Pay is from the Summary Compensation Table of each Rocket Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rocket PharmaceuticalsPublic company · 4 yr
    • Chief Technical Officer, Executive Vice President2022 – Present · 4 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?